Correlation Between Basilea Pharmaceutica and Komax Holding

Can any of the company-specific risk be diversified away by investing in both Basilea Pharmaceutica and Komax Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Basilea Pharmaceutica and Komax Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Basilea Pharmaceutica AG and Komax Holding AG, you can compare the effects of market volatilities on Basilea Pharmaceutica and Komax Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Basilea Pharmaceutica with a short position of Komax Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Basilea Pharmaceutica and Komax Holding.

Diversification Opportunities for Basilea Pharmaceutica and Komax Holding

-0.01

Correlation Coefficient

Basilea Pharmaceutica  Komax Holding

Good diversification

The 3 months correlation between Basilea and Komax is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Basilea Pharmaceutica AG and Komax Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Komax Holding AG and Basilea Pharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Basilea Pharmaceutica AG are associated (or correlated) with Komax Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Komax Holding AG has no effect on the direction of Basilea Pharmaceutica i.e., Basilea Pharmaceutica and Komax Holding go up and down completely randomly.

Pair Corralation between Basilea Pharmaceutica and Komax Holding

Assuming the 90 days trading horizon Basilea Pharmaceutica AG is expected to generate 0.54 times more return on investment than Komax Holding. However, Basilea Pharmaceutica AG is 1.87 times less risky than Komax Holding. It trades about 0.14 of its potential returns per unit of risk. Komax Holding AG is currently generating about 0.06 per unit of risk. If you would invest  4,095  in Basilea Pharmaceutica AG on December 2, 2024 and sell it today you would earn a total of  620.00  from holding Basilea Pharmaceutica AG or generate 15.14% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Basilea Pharmaceutica AG  vs.  Komax Holding AG

Basilea Pharmaceutica

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Basilea Pharmaceutica AG are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Basilea Pharmaceutica showed solid returns over the last few months and may actually be approaching a breakup point.

Komax Holding AG

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Komax Holding AG are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Komax Holding may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Basilea Pharmaceutica and Komax Holding

The main advantage of trading using opposite Basilea Pharmaceutica and Komax Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Basilea Pharmaceutica position performs unexpectedly, Komax Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Komax Holding will offset losses from the drop in Komax Holding's long position.

The idea behind Basilea Pharmaceutica AG and Komax Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.